|

PM8002 Clinical Trials

2 actively recruiting trials

No change since July 2026

Also known as: BNT327, Pumitamig

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • Biotheus Inc.2

Indications

  • Cancer2
  • CRC (Colorectal Cancer)1
  • Malignant Neoplasm1

Other2 trials

PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase 2
PM8002 in the Treatment of Patients With Advanced Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.